STTK

STTK
Name	STTK
Organism	Homo sapiens

STTK STTK is a putative human protein encoded by the STTK locus. It has been characterized in genomic surveys and proteomic screens and has been implicated in intracellular signaling, cellular adhesion, and transcriptional regulation through interactions with multiple well-known factors. Studies referencing large-scale projects and disease-focused consortia have placed STTK within networks connected to canonical pathways studied by investigators at institutions such as Harvard University, Massachusetts Institute of Technology, Stanford University, University of Cambridge, and consortia including ENCODE Project and Human Genome Project.

Introduction

STTK was first annotated in high-throughput sequencing efforts led by groups at National Institutes of Health and the Wellcome Sanger Institute. Subsequent mass spectrometry datasets from laboratories at Max Planck Institute for Biochemistry and European Bioinformatics Institute detected peptides mapping to the predicted STTK open reading frame, prompting biochemical follow-up at centers such as Cold Spring Harbor Laboratory and Broad Institute. Functional hypotheses emerged from computational predictions performed by teams at University of California, Berkeley and University of Oxford, and from phenotypic screens run by the Allen Institute for Cell Science and pharmaceutical companies including Pfizer and Novartis.

Gene and Protein Structure

The STTK gene resides on a human chromosome region identified and annotated in databases curated by Ensembl and UCSC Genome Browser. Its genomic architecture includes multiple exons and alternative splice sites cataloged in resources maintained by GENCODE and supported by transcriptome assemblies from GTEx Consortium and The Cancer Genome Atlas. The encoded STTK protein contains conserved motifs that align with domains characterized in the Pfam and SMART databases; structural homology modeling used templates from the Protein Data Bank and tools developed at European Molecular Biology Laboratory.

Primary sequence analyses revealed predicted transmembrane segments and low-complexity regions, with post-translational modification sites mapped through collaborations with groups at European Proteome Organisation and datasets from PRIDE Archive. Evolutionary conservation of STTK was assessed against orthologs cataloged by OrthoDB and NCBI HomoloGene, showing variable conservation across mammalian taxa studied at institutions such as University of Toronto and Monash University.

Expression and Regulation

Transcriptomic profiles for STTK were derived from RNA-seq datasets generated by the GTEx Consortium, single-cell atlases from Human Cell Atlas, and developmental time-course studies by labs at Salk Institute and University College London. Expression is reported as tissue-enriched in specific cell types per analyses by NIH Roadmap Epigenomics Program and chromatin accessibility data from ENCODE Project. Promoter and enhancer elements associated with STTK have been identified via ChIP-seq experiments employing antibodies characterized by groups at European Molecular Biology Laboratory and regulatory annotations from Roadmap Epigenomics Project.

Transcription factors implicated in STTK regulation include factors studied at Whitehead Institute and Cold Spring Harbor Laboratory, with regulatory motifs matching consensus sites cataloged in JASPAR and TRANSFAC. Epigenetic modulation through histone modifications and DNA methylation patterns was reported in studies from Johns Hopkins University and cancer epigenomics consortia such as ICGC.

Biological Function and Pathways

Functional studies suggest that STTK participates in intracellular signaling cascades and protein interaction networks mapped by interactome projects at Max Planck Institute for Molecular Cell Biology and Genetics and European Molecular Biology Laboratory. Pathway analyses linked STTK-associated partners to modules studied by investigators at Massachusetts General Hospital and Dana-Farber Cancer Institute, including connections to receptor-mediated endocytosis and cytoskeletal remodeling pathways characterized in work from Yale University and University of California, San Francisco.

Protein–protein interactions involving STTK were identified using affinity purification and proximity labeling methods developed at Stanford University and applied in datasets deposited by ProteomeXchange. Cross-talk with signaling nodes familiar from studies at MD Anderson Cancer Center and Memorial Sloan Kettering Cancer Center places STTK near regulators of cell migration, vesicle trafficking, and transcriptional co-regulation.

Clinical Significance and Disease Associations

Genetic variation at the STTK locus has been reported in genome-wide association studies cataloged by groups including Wellcome Trust Case Control Consortium and analyzed in meta-analyses from International HapMap Project contributors. Rare variants and copy-number changes affecting STTK were annotated in clinical databases curated by ClinVar and clinical sequencing initiatives at Broad Institute and Baylor College of Medicine. Correlative studies linked altered STTK expression to phenotypes examined at Memorial Sloan Kettering Cancer Center and Mayo Clinic, with associations to specific cancer subtypes, inflammatory conditions, and developmental disorders reported in cohorts assembled by UK Biobank and All of Us Research Program.

Therapeutic relevance is under investigation by academic drug-discovery programs at Scripps Research Institute and biotechnology companies following leads from translational centers such as Johns Hopkins University School of Medicine and University of Pennsylvania. Biomarker potential of STTK is being evaluated in retrospective analyses from clinical trials run by cooperative groups including National Cancer Institute networks.

Experimental Methods and Research Models

Studies of STTK have employed CRISPR methods popularized by groups at MIT and Broad Institute for gene knockout and allelic series, RNA interference screens established at Cold Spring Harbor Laboratory, and overexpression systems developed in labs at EMBL-EBI. Model organisms used include murine models generated at facilities such as Jackson Laboratory, zebrafish models from groups at Baylor College of Medicine, and cell-line systems derived and authenticated by centers including ATCC.

Biochemical characterization utilized mass spectrometry platforms at Max Planck Institute for Biochemistry and structural approaches using cryo-EM facilities at University of Cambridge and Stanford University. Functional assays incorporated live-cell imaging platforms pioneered at Allen Institute for Cell Science and high-throughput phenotyping pipelines at Broad Institute.

Category:Human proteins